Home > Newsletters > Drug Industry Daily > FDA Reorganizes Regulatory Affairs Office to Respond to Drug Industry Globalization
Drug Industry Daily
Sept. 20, 2012 | Vol. 11 No. 185
FDA Reorganizes Regulatory Affairs Office to Respond to Drug Industry Globalization
The FDA is planning to reorganize its Office of Regulatory Affairs (ORA), including creating new offices and reorganizing others, as it takes steps to dissolve cumbersome domestic and international distinctions and to keep up with increasingly global operations.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.